Article info

Download PDFPDF
Concise report
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

Authors

  1. Correspondence to Erik Hans Vogelzang, Department of Rheumatology, Jan van Breemen Research Institute | Reade, Dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands; e.vogelzang{at}reade.nl
View Full Text

Citation

Vogelzang EH, Kneepkens EL, Nurmohamed MT, et al
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

Publication history

  • Received March 11, 2014
  • Revised June 10, 2014
  • Accepted July 20, 2014
  • First published August 12, 2014.
Online issue publication 
October 30, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.